Aurora Spine Corporation

Equities

ASG

CA05206X1087

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E. Other stock markets 20:59:47 10/05/2024 BST			5-day change	1st Jan Change
0.265 ^CAD	0.00%		+6.00%	-33.75%

04-30	Aurora Spine Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-20	Aurora Spine on 2nd Anniversary of Implantation of First Bone Density Matched DEXA-C Cervical Interbody Fusion Device	MT

Aurora Spine Corporation to Showcase Sacroiliac Joint (Si Joint) Fusion Products At North American Neuromodulation Society Annual Meeting

January 18, 2024 at 12:21 pm

Aurora Spine Corporation announced that it will be participating in the North American Neuromodulation Society (NANS) Annual Meeting from January 18-21 in Las Vegas, Nevada. The NANS Annual Meeting is a prominent medical conference that brings together healthcare professionals, researchers, and experts in the field of neuromodulation. Aurora will be showcasing two Sacroiliac Joint (SI Joint) fusion products.

Silo TFX and Silo offer physicians options to stabilize the SI Joint, helping patients with access to treatment for their SI joint dysfunction. Aurora Spine will be presenting data from the recent publication of the first 6-month clinical evaluation from the REFINE Screwless? ZIP?

Study of its ZIP Interspinous Fixation device in the Journal of Pain Research.

Latest news about Aurora Spine Corporation

Aurora Spine Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
Aurora Spine on 2nd Anniversary of Implantation of First Bone Density Matched DEXA-C Cervical Interbody Fusion Device	03-20	MT
Aurora Spine's Second Patent Related To DEXA Technology Patient-Matched Implant Technology Issued by U.S. Patent Office	02-05	MT
Aurora Spine Corp Granted New US Patent	01-29	MT
Aurora Spine Corporation to Showcase Sacroiliac Joint (Si Joint) Fusion Products At North American Neuromodulation Society Annual Meeting	01-18	CI
Aurora Spine Corp Announces Published Paper on First 6-month Clinical Evaluation of its ZIP Fusion Implant	12-04	MT
Aurora Spine Corporation Announces Newly Published Paper on First 6-Month Clinical Evaluation of its ZIP?? Fusion Implant	12-04	CI
Aurora Spine Corp Announces Q3 2023 Results	11-15	MT
Transcript : Aurora Spine Corporation, Q3 2023 Earnings Call, Nov 15, 2023	11-15
Aurora Spine Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Aurora Spine Corporation announced that it has received CAD 1.933782 million in funding	22/10/23	CI
Aurora Spine Announces Full Release of its SiLO TFX MIS Sacroiliac Joint Fixation System	13/09/23	MT
Aurora Spine Corporation Announces Full Release of its SiLO TFX?? MIS Sacroiliac Joint Fixation System	13/09/23	CI
Transcript : Aurora Spine Corporation, Q2 2023 Earnings Call, Aug 29, 2023	29/08/23
Aurora Spine Reports Q2 2023 Net Loss of US$0.01 Per Share	23/08/23	MT
Aurora Spine Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/08/23	CI
Aurora Spine Up After Announcing Initial Patient Enrolled for DEXA-CTM Multicenter Study	28/06/23	MT
Aurora Spine Corporation Announces Initial Patient Enrolled for DEXA-CTM Multicenter Study	28/06/23	CI
Transcript : Aurora Spine Corporation, Q1 2023 Earnings Call, May 24, 2023	24/05/23
Aurora Spine Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	22/05/23	CI
Transcript : Aurora Spine Corporation, Q4 2022 Earnings Call, May 01, 2023	01/05/23
Aurora Spine Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	29/04/23	CI
Aurora Spine Corporation Auditor Raises 'Going Concern' Doubt	27/04/23	CI
Aurora Spine Corporation to Showcase SiLO TFXTM SI Fusion System At American Association of Neurological Surgeons Annual Scientific Meeting	19/04/23	CI
Aurora Spine Announces Initial Surgeries Conducted Using its Sacroiliac Joint Fixation System	17/04/23	MT

Chart Aurora Spine Corporation

Duration

Period

More charts

Company Profile

Aurora Spine Corporation is a designer and manufacturer of medical devices. The Company is engaged in the development and distribution of minimally invasive, interspinous fusion systems and devices. Its product line includes implants, surgical tools and biologics. Its implants include Cervical Products, Thoraco-Lumbar Products, and SI joint products. The surgical tools include Anterior Disc Prep, Posterior Disc Prep and Compass 4D Retractor System. The biologics consist of ZIP Graft and SiLO Si-Fusion. The Company is focused on DEXA technology, which opens up treatment for osteoporotic patients. It offers DEXA-C Cervical Implants Featuring Visual Density Markers, and DEXA -L Standalone Anterior Lumbar Interbody Fusion System.

Sector

Medical Equipment, Supplies & Distribution

Calendar

12/05/2024 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
AURORA SPINE CORPORATION	-33.75%	15.02M
ABBOTT LABORATORIES	-4.84%	182B
MEDTRONIC PLC	+0.56%	110B
BECTON, DICKINSON AND COMPANY	-3.35%	68.11B
DEXCOM, INC.	+2.39%	50.53B
CENCORA, INC.	+9.36%	44.8B
HOYA CORPORATION	+2.70%	40.7B
WEST PHARMACEUTICAL SERVICES, INC.	+3.43%	26.53B
TERUMO CORPORATION	+13.67%	25.02B
ZIMMER BIOMET HOLDINGS, INC.	-0.32%	24.96B

Other Medical Equipment, Supplies & Distribution